By preserving critical residues that have interaction with the GHRH receptor, tesamorelin proficiently stimulates downstream signaling pathways that govern GH secretion through the anterior pituitary. The U.S. Meals and Drug Administration (FDA) has accepted tesamorelin to the treatment method of lipodystrophy in sufferers with HIV. This accepta